99mTc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities.
Luca M GiovanellaGaetano PaoneTeresa RubertoLuca CerianiPierpaolo TrimboliPublished in: Endocrinology and metabolism (Seoul, Korea) (2019)
The 99mTc-pertechnetate scintigraphy is a simple and feasible tool to predict effectiveness of low activity ¹³¹I thyroid to ablate thyroid remnants in patients with DTC.